Obesity Indices Could Predict High Apolipoprotein B/Apolipoprotein A1 Ratio in Non-menopausal Indonesian Adult Females
DOI:
https://doi.org/10.24293/ijcpml.v29i2.2049Keywords:
Apolipoprotein B/Apolipoprotein A1 Ratio, Obesity, non-menopausal femaleAbstract
Previous researches have demonstrated associations between high obesity indices with increased risk of metabolic and cardiovascular disorders. It has also been established that abnormalities of lipoprotein metabolism have an important role in atherogenesis and that non-menopausal females are protected from atherosclerotic cardiovascular events relative to menopausal females and males. This study aimed to investigate the relationship between obesity indices such as body mass index (BMI), waist circumference (WC), body fat percentage (BF), and visceral fat (VF) with apolipoprotein B/apolipoprotein A1 ratio in non-menopausal Indonesian adult females. A total of 75 non-menopausal Indonesian adult females were included as subjects in this cross-sectional study. Measured indices included BMI, WC, BF, and VF. Measurement of apolipoprotein B and A1 were performed by immunoturbidimetry, followed by calculation of the ratio. A cut-off value of 0.8 was used to define high apolipoprotein B/apolipoprotein A1 ratio. Apolipoprotein B/Apolipoprotein A1 ratio was significantly correlated with BMI (r=0.384, p=0.001), WC (r=0.363, p=0.001), BF (r=0.385, p=0.001), VF (r=0.380, p=0.001). The area under curve of BF (0.754) was slightly larger than BMI (0.722), VF (0.721), and WC (0.686) in predicting high apolipoprotein B/apolipoprotein A1 ratio. A positive significant correlation was observed between obesity indices with the apolipoprotein B/apolipoprotein A1 ratio. Obesity indices could be used to predict high apolipoprotein B/apolipoprotein A1 ratio.
Downloads
References
Seidell JC, Halberstadt J. The global burden of obesity and the challenges of prevention. Ann Nutr Metab, 2015; 66(suppl 2): 7-12.
Harbuwono DS, Pramono LA, Yunir E, Subekti I. Obesity and central obesity in Indonesia: evidence from a national health survey. Med J Indones, 2018; 27: 114-120.
Drozdz D, Alvarez-Pitti J, Wojcik M, Borghi C, Gabbianelli R, et al. Obesity and cardiometabolic risk factors: From childhood to adulthood. Nutrients, 2021; 13: 4176.
Wang HH, Garruti G, Liu M, Portincasa P, Wang DQH. Cholesterol and lipoprotein metabolism and atherosclerosis: Recent advances in reverse cholesterol transport. Ann Hepatol, 2017; 16(suppl 1): s27-s42.
Sniderman AD, Thanassoulis G, Glavinovic T, Navar AM, Pencina M, Catapano A, et al. Apolipoprotein B particles and cardiovascular disease: A narrative review. JAMA Cardiol, 2019; 4(12): 1287-1295.
Chou YC, You SL, Bai CH, Liao YC, Wei CY, Sun CA. Utility of apolipoprotein measurements in predicting incident type 2 diabetes: A Chinese cohort study. J Formos Med Assoc, 2020; 119: 51-58.
Frondelius K, Borg M, Ericson U, Borne Y, Melander O, Sonestedt E. Lifestyle and dietary determinants of serum apolipoprotein A1 and apolipoprotein B concentration: Cross-sectional analyses within a Swedish cohort of 24,984 individuals. Nutrients, 2017; 9: 211.
War GA, Raina S, Jain R, Kant S. Correlation of apolipoprotein B and apolipoprotein A1 with metabolic syndrome–single center experience from Delhi. JIACM, 2018; 19(3): 191-194.
Kaneva A, Potolitsyna NN, Bojko ER, Odland JO. The apolipoprotein B/apolipoprotein A-I ratio as a potential marker of plasma atherogenity. Disease Markers, 2015; Article ID 591454.
Palmisano BT, Zhu L, Eckel RH, Stafford JM. Sex difference in lipid and lipoprotein metabolism. Mol Metab, 2018; 15: 45-55.
Nam GE, Park HS. Perspective on diagnostic criteria for obesity and abdominal obesity in Korean adults. J Obes Metab Syndr, 2018; 27: 134-142.
American Diabetes Association. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2018. Diabetes Care, 2018; 41(suppl. 1): S13-S27.
Gutch M, Kumar S, Razi SM, Gupta KK, Gupta A. Assessment of insulin sensitivity/resistance. Indian J Endocrinol Metab, 2015; 19(1): 160-164.
Vanavanan S, Srisawasdi P, Rochanawutanon M, Kumproa N, Kruthkul K, Kroll MH. Performance of body mass index and percentage of body fat in predicting cardiometabolic risk factors in Thai adults. Diabetes Metab Syndr Obes, 2018; 11: 241-253.
Eslami O, Shahraki M, Shahraki T. Obesity indices in relation to lipid abnormalities among medical university students in Zahedan, south-east of Iran. Int J Prev Med, 2019; 10: 15.
Wang W, Blackett P, Khan S, Lee E. Apolipoproteins A-I, B, and C-III and obesity in young adult Cherokee. J Lipids, 2017; Article ID 8236325.
Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuniga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol, 2018; 17: 122.
Morita S. Metabolism and modification of apolipoprotein B-containing lipoproteins involved in dyslipidemia and atherosclerosis. Biol Pharm Bull, 2016; 39: 1-24.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
